Andrew Penkethman – CEO & Managing Director – Ardea Resources (ASX:ARL) is an ASX-listed nickel resources company, with a large portfolio of 100%-controlled West Australian-based projects.
Copyright 2024 – Finance News Network
Source: Finance News Network
12 Aug 2020 - Galan Lithium Limited (ASX:GLN) Managing Director, Juan Pablo Vargas de la Vega talks about the company's lithium brine projects located within the South American Lithium Triangle in Argentina strategy and near-term targets.
Read More10 Oct 2023 - Tim Wither - Managing Director - Maximus Resources (ASX:MXR) is a gold and nickel exploration company.
Read More01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
Read More04 May 2023 - Phil Hoskins, Managing Director of Evolution Energy Minerals (ASX:EV1), discusses EV1's Tanzanian Graphite project, the recent updated DFS and the formal signing of framework agreement with the Tanzanian Government.
Read More25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Dean Tuck, Managing Director of Dreadnought Resources (ASX:DRE).
Read More25 May 2023 - Mad Paws Limited (ASX:MPA) Managing Director Justus Hammer discusses the company's business model, effects of the macro environment, competition and differentiation, the company's online marketplace and ecosystem, M&A opportunities, the integration of Pet Chemist and outlook.
Read More09 Feb 2023 - Sequoia Asset Management Investment Manager Winston Sammut discusses property investment strategy, the impacts of COVID and work from home, shopping malls, industrial property, and alternative property classes.
Read More17 Jan 2022 - eCargo Holdings Limited (ASX:ECG) Head of Corporate Marketing Lewis Bacon provides an insight into how eCommerce will continue to grow in China and across Asia, and eCargo’s position to assist brands with market entry.
Read More03 Jun 2020 - Cyclopharm (ASX:CYC) Managing Director and CEO James McBrayer provides an update on US FDA progress with Technegas, approval in Russia and potential use of Technegas in the diagnosis and management of COVID-19.
Read More16 Apr 2025 - Managing Director Jarrad Haynes shares how the firm is navigating risk, scaling development, and positioning for long-term growth.
Read More
